title: Early electrocardiographic changes in acute myocardial infarction treated by streptokinase or alteplase: a randomized study with dynamic, multi-lead, electrocardiographic monitoring.
abstract: Patients with a patent coronary artery after reperfusion therapy show an increased rate of evolution of QRS changes and of resolution of S-T changes as compared to patients with a persistent occlusion. Dynamic vectorcardiography permits multi-lead monitoring of changes in QRS complex and S-T segment over time. We monitored 150 patients randomized to alteplase or streptokinase for 24 h after admission. Alteplase was associated with significantly more rapid evolution of electrocardiographic changes but also with an increased occurrence of recurrent S-T changes. This may indicate a higher rate of early reperfusion with alteplase but due to recurrent ischemia, an electrocardiographic catch-up is seen with similar extent of myocardial damage observed after 24 h of monitoring.
authors.affiliation: Department of Medicine, Ostra Hospital, University of Göteborg, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Dellborg
authors.forename: A M
authors.initials: AM
authors.lastname: Svensson
authors.forename: M
authors.initials: M
authors.lastname: Johansson
authors.forename: K
authors.initials: K
authors.lastname: Swedberg
mesh_terms: D000368:Aged; D003326:Coronary Circulation / Q000187:drug effects / Q000502:physiology; D005260:Female; D006329:Heart Conduction System / Q000503:physiopathology; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D015425:Myocardial Reperfusion; D011379:Prognosis; D013300:Streptokinase / Q000627:therapeutic use*; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014672:Vectorcardiography / Q000187:drug effects*
chemical_list: D013300:Streptokinase; D010959:Tissue Plasminogen Activator